VIETNAMESE VERSION OF THE LUPUS-PRO QUESTIONNAIRE: STRUCTURAL VALIDITY AND RELIABILITY
Main Article Content
Abstract
Introduction: Lupus-PRO is a disease-specific quality of life (QoL) questionnaire designed for patients with systemic lupus erythematosus (SLE). Although the Lupus-PRO questionnaire has been translated into Vietnamese, it has not yet been validated in Vietnamese patients. Objective: To evaluate the structural validity and reliability of the Vietnamese version of the Lupus-PRO questionnaire. Methods: This study was conducted on 91 SLE patients who were managed and monitored at the Lupus Management Unit, Outpatient Department, Bach Mai Hospital, from March 2021 to December 2021. Patients were interviewed about their QoL using the Vietnamese version of the Lupus-PRO questionnaire. Structural validity was assessed by comparing QoL scores among different patient groups. Reliability was evaluated using Cronbach’s alpha coefficient. Results: The Vietnamese version of the Lupus-PRO questionnaire demonstrated structural validity, as significant differences in QoL scores were observed among patients with different educational levels (p = 0.025) and comorbidities (p = 0.001). The questionnaire exhibited high reliability, with an overall Cronbach’s alpha coefficient of 0.910. Conclusion: The Vietnamese version of the Lupus-PRO questionnaire meets the criteria for structural validity and internal reliability, making it suitable for assessing QoL in SLE patients.
Article Details
Keywords
systemic lupus erythematosus, quality of life, validity, reliability
References

2. Nguyen, M. H., Huang, F. F., & O'Neill, S. G. (2021), Patient-Reported Outcomes for Quality of Life in SLE: Essential in Clinical Trials and Ready for Routine Care. Journal of clinical medicine, 10(16), 3754.

3. Rush edu. About the LupusPRO Survey. https://www.rush.edu/lupuspro/lupuspro-about#translate. August 1st, 2024.

4. Nguyen, T., Tran, T., Diep, H., Vo, S., Taxis, K., & Nguyen, T. (2022), Adaptation and Validation of the Vietnamese Translated Diabetes Knowledge Questionnaire. Journal of the ASEAN Federation of Endocrine Societies, 37(1), 38–45.

5. Bowling A. (2014). Research Methods in Health. 4th ed. New York: McGraw Hill.

6. Bourré-Tessier, J., Clarke, A. E., Kosinski, M., Mikolaitis-Preuss, R. A., Bernatsky, S., Block, J. A., & Jolly, M. (2014), The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus. Lupus, 23(14), 1452–1459.

7. Pinto, B., Jolly, M., Dhooria, A., Grover, S., Raj, J. M., Devilliers, H., & Sharma, A. (2019), Hindi LupusPRO: cross cultural validation of disease specific patient reported outcome measure of lupus. Lupus, 28(13), 1534–1540.

8. Inoue, M., Shiozawa, K., Yoshihara, R., Yamane, T., Shima, Y., Hirano, T., Jolly, M., & Makimoto, K. (2017), The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus. Lupus, 26(8), 849–856.
